Science and Discovery

Lung Cancer

2 articles

A glowing blood sample in a vial, representing a new 14-protein blood test for predicting lung cancer risk.
Cosmos & Space

Researchers find 14-protein blood test predicting lung cancer risk

In a groundbreaking re-analysis, an existing anti-inflammatory drug nearly halved lung cancer risk in individuals identified by a specific 14-protein blood signature.

Marcus Cole·June 9, 2026
A dimly lit laboratory with a microscope, symbolizing the disappointment of a failed Parkinson's drug trial.
Cosmos & Space

Merck Halts Parkinson's Drug Program After Phase 3 Setback

Merck's Parkinson's drug, preladenant, was discontinued in 2026 after Phase 3 trials showed it was no more effective than a placebo.

Aram Sarkisian·May 22, 2026